COMMUNIQUÉS West-GlobeNewswire

Canada House Wellness Group Update on Abba Medix Grow Progress

18/01/2018 - 14:29

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Abba Medix Corp “Abba”, a subsidiary of Canada House Wellness Group Inc. (CSE:CHV) (“ [...]

Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results

18/01/2018 - 14:05

SAN DIEGO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) will host a conference call on Thursday, February 8, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal [...]

Celsion Corporation Provides Corporate Update and 2018 Outlook

18/01/2018 - 14:00

Company Advances ThermoDox® for Treatment of Primary Liver Cancer Following Independent Data Monitoring Committee’s Unanimous Recommendation to Continue Phase III OPTIMA Study OPTIMA Study Enrollment Reached 74% [...]

Radient Technologies Inc. Announces Key Management Appointment to RTI Global Health and Wellness Solutions

18/01/2018 - 14:00

EDMONTON, Alberta, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. ("Radient" or the “Corporation”) (TSX-V: RTI ) is pleased to announce the appointment of Dr. Marilena Radoiu to a key management role in its [...]

Argos Announces One-for-Twenty Reverse Stock Split

18/01/2018 - 14:00

DURHAM, N.C., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis [...]

Caladrius Biosciences Announces Completion of Enrollment of Phase 2 T-Rex Clinical Trial of CLBS03 for Type 1 Diabetes

18/01/2018 - 14:00

BASKING RIDGE, N.J. , Jan. 18, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]

AzurRx BioPharma Announces Receipt of Required Approvals to Add French Clinical Site for its Phase IIa Study of MS1819-SD for Exocrine Pancreatic Insufficiency

18/01/2018 - 14:00

BROOKLYN, N.Y., Jan. 18, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]

DiaMedica Letter to Shareholders

18/01/2018 - 14:00

MINNEAPOLIS, Jan. 18, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (“ DiaMedica ”) (TSX VENTURE:DMA) (OTCQB:DMCAF), provides corporate update. As we enter into 2018, we wanted to thank you, our shareholders, for [...]

REPEAT: Cannabis Wheaton Income Corp. Announces Closing of $100 Million Private Placement of Convertible Debenture Units

18/01/2018 - 13:30

VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or the " Company ") is pleased to announce the closing of its [...]

Loop Industries Announces Strategic Initiative to Support evian’s Commitment to Adopt a Circular Approach to Plastic Usage

18/01/2018 - 13:30

MONTREAL, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Loop™ Industries, Inc. (NASDAQ: LOOP ) (the “Company” or “Loop”), a leader in the sustainable plastic revolution, today announced a strategic initiative with evian® as part of [...]

Strongbridge Biopharma Receives Notice of Allowance from U.S. Patent and Trademark Office for New Patent Covering RECORLEV™ (levoketoconazole) for the Treatment of Cushing’s Syndrome

18/01/2018 - 13:30

DUBLIN, Ireland and TREVOSE, Pa., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]

The Joint Corp. Opens 400th Clinic

18/01/2018 - 13:05

SCOTTSDALE, Ariz., Jan. 18, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT ), a national operator, manager and franchisor of chiropractic clinics, reached 400 open clinics systemwide in January, 2018, having [...]

Immunovaccine Names Joseph Sullivan, Experienced Global Pharmaceutical and Vaccine Executive, as Senior Vice President, Business Development

18/01/2018 - 13:05

HALIFAX, Nova Scotia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that it has appointed Joseph Sullivan to the newly created [...]

Angel Yeast Co., Ltd. signs exclusive global licence agreement with Renaissance BioScience Corp. for wine, cider and craft beer yeast

18/01/2018 - 13:00

YICHANG, China and VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Angel Yeast Co., Ltd., a Shanghai Stock Exchange listed company (SSE:600298), has signed a global licence agreement with Renaissance [...]

Melinta Therapeutics Announces Initiation of Program for Radezolid in Patients with Bacterial Vaginosis

18/01/2018 - 13:00

NEW HAVEN, Conn., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, [...]

THC Therapeutics becomes Millennium Blockchain

18/01/2018 - 13:00

LAS VEGAS, Jan. 18, 2018 (GLOBE NEWSWIRE) -- THC Therapeutics, Inc. (“THCT” or the “Company,”) (OTC:THCT) is pleased to announce that it is changing its direction to blockchain technology. The Company is changing its [...]

Purepoint Uranium Reports on First Seven Holes at Hook Lake, Extending Spitfire Strike Length by 25%

18/01/2018 - 12:45

TORONTO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Purepoint Uranium Group Inc. (the “ Company ” or “ Purepoint ”) (TSX.V:PTU) today reported the completion of the first seven holes of the 2017/2018 Winter drill program at the [...]

Diffusion Pharmaceuticals Announces $12 Million Underwritten Public Offering

18/01/2018 - 12:00

CHARLOTTESVILLE, Va., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN ) (“Diffusion” or the “Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]

Sandoz announces exclusive global collaboration with Biocon on next-generation biosimilars

18/01/2018 - 11:31

Collaboration aims to help patients worldwide gain access to a range of high-quality, affordable immunology and oncology biologics Partnership will be an important part of Sandoz and Biocon strategy to address the next [...]